Clarity Pharmaceuticals

Sydney, Australia | April 14, 2026 Clarity Pharmaceuticals has announced the signing of a Commercial Manufacturing Agreement with Nucleus...

SYDNEY, Australia, March 31, 2026 Clarity Pharmaceuticals has announced the publication of Phase II Co-PSMA clinical trial results in...

SYDNEY, Australia, Feb. 23, 2026 — Clarity Pharmaceuticals announced a significant clinical milestone in the ongoing SECuRE Trial, reporting...

SYDNEY, Australia, Feb. 16, 2026 — Clarity Pharmaceuticals announced new clinical data from the Co-PSMA Investigator-Initiated Trial demonstrating that...